| |
Nitazoxanide in the treatment of acquired immune deficiency
syndrome-related
cryptosporidiosis: results of the United States compassionate use
program in 365 patients
Rossignol JF.
Aliment Pharmacol Ther. 2006 Sep 1;24(5):887-94
Abstract
Effect of nitazoxanide on morbidity and mortality in Zambian children with
cryptosporidiosis:
a randomised controlled trial.
Amadi B, Mwiya M, Musuku J, et al.
Lancet 2002 Nov 2;360(9343):1375-1380
Abstract
|
Nitazoxanide pharmacokinetics and tolerability in man during 7 days dosing
with 0.5 g
and 1 g b.i.d.
Stockis A, De Bruyn S, Gengler C,
Rosillon D.
Int J Clin Pharmacol Ther 2002 May;40(5):221-7
Abstract
|
Treatment of diarrhea caused by Cryptosporidium parvum: a prospective
randomized,
double-blind, placebo-controlled study of Nitazoxanide.
Rossignol JF, Ayoub A, Ayers MS.
J Infect Dis 2001 Jul 1;184(1):103-6
Abstract
|
A double-'blind' placebo-controlled study of nitazoxanide in the treatment
of cryptosporidial
diarrhoea in AIDS patients in Mexico.
Rossignol JF, Hidalgo H, Feregrino M.
Trans R Soc Trop Med Hyg 1998
Nov-Dec;92(6):663-6
Abstract
|
Nitazoxanide in the treatment of cryptosporidial diarrhea and other
intestinal parasitic
infections associated with acquired immunodeficiency
syndrome in tropical Africa.
Doumbo O, Rossignol JF, Pichard E, et al.
Am J Trop Med Hyg 1997
Jun;56(6):637-9
Abstract |
|
|
|
Antiretrovirals 
Cryptosporidiosis
Main Page
Documents identified with this icon are in Portable Document Format (PDF)
and require the
Adobe
Acrobat Reader